Comparison of intravoxel incoherent motion and diffusion kurtosis imaging and 18- FDG PET/CT in response assessment in rectosigmoid carcinoma
- 25 November 2024
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (6) , 2339-2350
Abstract
Objective To evaluate the performance of intravoxel incoherent motion and diffusion kurtosis imaging (IVIM- DKI) in response assessment of rectosigmoid carcinoma to chemo-radiotherapy (CRT) and compare with 18-FDG PET/CT parameters. Methods A total of 30 patients of recto-sigmoid cancer on CRT underwent baseline staging and follow-up with IVIM - DKI. Out of this cohort, 20 patients underwent 18-FDG PET/CT. IVIM- DKI MRI and PET/CT parameters were noted from both pre and post-chemoradiotherapy (done at 6 weeks after completion) scans. Quantitative IVIM-DKI parameters, viz. apparent (ADC) and molecular (D) diffusion coefficient, perfusion coefficient (f), and kurtosis (K) were measured from non-necrotic areas and semi-quantitative PET parameters including SUV max, SUV ratio, metabolic tumor volume (MTV), total lesion glycolysis (TLG) were also measured. All these parameters correlated with the patient’s response keeping RECIST 1.1 criteria as reference standard. Results A statistically significant increase in D and ADC with a significant decline in K was noted after therapy in the entire cohort. These changes were observed in both responders as well as non-responders. No significant differences were observed in the percentage changes of these parameters post therapy amongst both groups. Among 20 patients with follow-up PET/CT imaging, a significant decline in all parameters of primary lesion was seen post-therapy. Responders (n = 12) showed a significant decline in MTV and TLG from baseline after therapy, whereas non-responders did not show any such decline. Change in TLG (ɗ TLG), followed by ɗ MTV had the strongest correlation with a positive response. A ɗ TLG value of ≥ 54.19 carried a 79% sensitivity and 83% specificity in differentiating responders from non responders. Conclusion 18-FDG PET/CT is a more accurate single modality for assessing both response and tumor burden post therapy, while ADC and D from IVIM MRI are useful adjuncts to response assessment.Keywords
This publication has 33 references indexed in Scilit:
- FDG PET/CT Can Assess the Response of Locally Advanced Rectal Cancer to Neoadjuvant ChemoradiotherapyClinical Nuclear Medicine, 2016
- Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practiceJournal of Magnetic Resonance Imaging, 2015
- Advances and Challenges in Treatment of Locally Advanced Rectal CancerJournal of Clinical Oncology, 2015
- Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancerSurgery Today, 2014
- Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcomeEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- The Predictive Role of Sequential FDG-PET/CT in Response of Locally Advanced Rectal Cancer to Neoadjuvant ChemoradiationAmerican Journal of Clinical Oncology, 2012
- An in vivo verification of the intravoxel incoherent motion effect in diffusion‐weighted imaging of the abdomenMagnetic Resonance in Medicine, 2010
- Locally Advanced Rectal Cancer: Added Value of Diffusion-weighted MR Imaging in the Evaluation of Tumor Response to Neoadjuvant Chemo- and Radiation TherapyRadiology, 2009
- Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission TomographyAnnals of Surgery, 2001
- Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patientsBritish Journal of Surgery, 1985